Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mixed Dyslipidemias”

152 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 152 results

Not applicableActive Not RecruitingNCT04579367
What this trial is testing

Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed Dyslipidemia

Who this might be right for
HypercholesterolemiaMixed Dyslipidemia
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 5,000
Large-scale testing (Phase 3)Study completedNCT00269217
What this trial is testing

Lipid Efficacy Study (0524B-022)(COMPLETED)

Who this might be right for
Primary HypercholesterolemiaMixed Hyperlipidemia
Merck Sharp & Dohme LLC 1,400
Post-approval studies (Phase 4)WithdrawnNCT00738985
What this trial is testing

Efficacy of Ezetimibe/Simvastatin 10/20 mg and MK0524A (1-2 g/Day) in Mixed Hyperlipidemia and Two or More Risk Factors

Who this might be right for
Cardiovascular DiseasesHyperlipidemia
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Not applicableStudy completedNCT07119658
What this trial is testing

Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial

Who this might be right for
HypertensionHyperglycemiaDyslipidemia+5 more
Indiana University 20
Not applicableWithdrawnNCT05798390
What this trial is testing

Treatment With Bempedoic Acid And/Or Its Fixed-dose Combination With Ezetimibe in Routine Clinical Practice in Patients With Primary Hypercholesterolemia Or Mixed Dyslipidemia

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Early research (Phase 1)Study completedNCT06923956
What this trial is testing

Single Dose Oral Bioequivalence Study of Bempedoic Acid 180 mg Film Coated Tablet and Nilemdo® (Bempedoic Acid) 180 mg Film-coated Tablets in Healthy Adult Human Subjects Under Fasting Conditions.

Who this might be right for
HypercholesterolaemiaMixed DyslipidaemiaCardiovascular Diseases
Humanis Saglık Anonim Sirketi 14
Large-scale testing (Phase 3)Study completedNCT00300430
What this trial is testing

Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia.

Who this might be right for
DyslipidemiaCoronary Heart DiseaseMixed Dyslipidemia
Abbott 1,911
Large-scale testing (Phase 3)Study completedNCT04781114
What this trial is testing

The Safety and Efficacy of Multiple-dose of JS002 in Subject With Hyperlipidemia

Who this might be right for
Hyperlipemia
Shanghai Junshi Bioscience Co., Ltd. 806
Large-scale testing (Phase 3)Study completedNCT02262143
What this trial is testing

Phase III Study of Rosuvastatin and Fenofibrate Versus Rosuvastatin in Mixed Dyslipidemia

Who this might be right for
Mixed Dyslipidemias
IlDong Pharmaceutical Co Ltd 362
Not applicableStudy completedNCT02730559
What this trial is testing

Motivational Interviewing With Dyslipidemic Adolescents Together With a Parent Versus With Adolescents Alone: A Mixed Methods Clinical Trial

Who this might be right for
Dyslipidemias
The Hospital for Sick Children 32
Large-scale testing (Phase 3)WithdrawnNCT05809687
What this trial is testing

Phase 3 Trial to Evaluate the Efficacy and Safety of DKP21102_B Added on to DKP21102_A Compared With DKP21102_A

Who this might be right for
Dyslipidemias
Dongkwang Pharm. Co., Ltd.
Large-scale testing (Phase 3)WithdrawnNCT02799758
What this trial is testing

Efficacy & Long-term Safety Comparison Study of NK-104-CR & Livalo® IR With Primary Hyperlipidemia or Mixed Dyslipidemia

Who this might be right for
HyperlipidemiaDyslipidemia
Kowa Research Institute, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT01972178
What this trial is testing

Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia

Who this might be right for
Dyslipidemia
Pronova BioPharma 113
Large-scale testing (Phase 3)Study completedNCT02458287
What this trial is testing

Efficacy, Safety, Tolerability And Actual Use Study Of Bococizumab And An Autoinjector (Pre-Filled Pen) In Subjects With Hyperlipidemia Or Dyslipidemia

Who this might be right for
Hyperlipidemia
Pfizer 299
Large-scale testing (Phase 3)Study completedNCT00093899
What this trial is testing

Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED)

Who this might be right for
HyperlipidemiaHypercholesterolemiaHypertriglyceridemia
Organon and Co 611
Large-scale testing (Phase 3)Study completedNCT04643093
What this trial is testing

Compare the Efficacy and Safety of 1PC111 With Pitavastatin and Ezetimibe in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemias
Orient Pharma Co., Ltd. 390
Testing effectiveness (Phase 2)Study completedNCT04516291
What this trial is testing

A Dose-Ranging Study With Vupanorsen (TRANSLATE-TIMI 70)

Who this might be right for
DyslipidemiasHyperlipidemiasHyperlipoproteinemias
Pfizer 286
Testing effectiveness (Phase 2)Study completedNCT07421232
What this trial is testing

Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia

Who this might be right for
Hypercholesterolemia and Mixed Hyperlipidemia
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 156
Testing effectiveness (Phase 2)Study completedNCT04998201
What this trial is testing

Study of Plozasiran (ARO-APOC3) in Adults With Mixed Dyslipidemia

Who this might be right for
Mixed Dyslipidemia
Arrowhead Pharmaceuticals 353
Not applicableStudy completedNCT05118230
What this trial is testing

Study to Assess the Real World Effectiveness of Inclisiran in Chinese Adult Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Novartis Pharmaceuticals 61
Next Page